Crescent Diagnostics Secures Venture Capital Financing

Published: Jun 13, 2006

LONDON, June 13 /PRNewswire/ -- Crescent Diagnostics Ltd. (Crescent), a privately held company developing a new test for bone health, today announced the completion of a GBP 550,000 (Euros 800,000) funding round. Seroba BioVentures (Seroba), a Dublin-based specialist life science venture capital firm led the round in conjunction with a number of private investors.

Back to news